Author Disclosure Statement
Zilia
DISEASES, FOUNDER, EYE, ROBINSON
Robert N. Weinreb: consultant for AbbVie, Aerie Pharmaceuticals, Allergan, Equinox, Eyenovia, Iantrek, Implandata, IOPtic, Nicox, and Topcon; research support from Bausch + Lomb, Carl Zeiss Meditec, Centervue, Heidelberg Engineering, National Eye Institute, National Institute of Minority Diseases and Health Disparities, Optovue, Topcon, and Zilia; and founder of Toromedes.Jason Bacharach: consultant and on the speaker's bureau for, and receives research support from, Allergan (an AbbVie company).Jacob W. Brubaker: consultant for and has received research support from Allergan (an AbbVie company), Aerie Pharmaceuticals, Equinox, Glaukos, Alcon, and Santen; consultant for Iridex and New World Medical; and receives research support from Nicox and Twenty/Twenty Therapeutics.Felipe A. Medeiros: consultant for Aerie Pharmaceuticals, Allergan (an AbbVie company), Annexon, Biogen, Carl Zeiss Meditec, Galimedix, Novartis, Reichert, and Stealth BioTherapeutics; research support from Carl Zeiss Meditec, Google, Heidelberg Engineering, and Reichert; and founder of NGoggle, Inc.Marina Bejanian and Michael R. Robinson: employee of AbbVie, Inc.Paula Bernstein: contractor for AbbVie, Inc.